Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent manners
about
Current vaccine trials in glioblastoma: a reviewHarnessing immunosurveillance: current developments and future directions in cancer immunotherapyIntegration of epidemiology, immunobiology, and translational research for brain tumorsIntratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenograftsAntigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstemInduction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcelluloSystemic delivery of neutralizing antibody targeting CCL2 for glioma therapy.Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses.Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer TherapyTumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of gliomaManipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer Therapies.Prioritization schema for immunotherapy clinical trials in glioblastoma.Immune-checkpoint blockade and active immunotherapy for glioma.Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".Modulation of tumor tolerance in primary central nervous system malignancies.Vaccine adjuvant uses of poly-IC and derivatives.In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.In situ vaccination for the treatment of cancer.Novel therapeutic strategies in human malignancy: combining immunotherapy and oncolytic virotherapy.Tumor Vaccines for Malignant Gliomas.Interferon regulatory factor 3 alters glioma inflammatory and invasive properties.New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas.Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.Tumor Immuno-Environment in Cancer Progression and Therapy.Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade.Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
P2860
Q26828965-36DDA318-D54E-47EC-A12A-134E8B4D32F5Q27021570-E3F12410-6476-4C5E-9F18-EB58AE923B31Q28397886-A0DB1369-12FD-46E9-99C4-F914A87884DFQ30276128-DBE92E54-83A7-44F1-8DB3-B2BB52FDCDB7Q30425111-FD83CDB8-433C-4853-ADD9-01A59C7A0F3CQ33606096-FC2D6AF2-AA4E-4D28-A9FB-4B027451DED2Q33796170-6A969969-5AE5-4838-A362-BC3789907ED8Q34666875-78CAEBD9-B529-4A11-9DEE-A9A8557ECF1BQ34744555-7F9D9C65-F963-42C8-8D16-EAA3B9C2FCB2Q34979511-2FE0511D-9816-4D18-B7B8-9D16EC264FACQ35028032-6C2D8881-8B4A-4B65-B688-66742E351D7DQ35826624-AB2F50AD-496A-4B0F-9F56-A64970B499B0Q36039709-84C3EAF6-F0A6-456E-9B01-33BDC5B09976Q36057502-0FBB4CD7-8C32-48CB-A02B-0300C019355EQ36796025-81D0BB2C-241E-45D0-A15B-509D127D802EQ37078999-9EB96229-1F04-4809-AC20-F4B04A91CD30Q37420586-A1D1ECC5-21DD-4788-A46C-E0C31E5497E4Q37730613-B3D1AB0D-2ED5-4A18-9AA8-9042C3B1794BQ37919880-C8B454B7-A801-4382-B45B-C5F71D254D94Q37982065-2E3E8DED-A39F-46D3-9489-5E6E1ADB63CEQ38259510-A76F0E20-0823-466D-BB4E-83BFC8A0EFDBQ38657642-6CACF082-6CD3-4F62-A844-65610B229E7BQ38727470-723E8449-1B27-4935-99A7-AEEBD318A568Q38924557-74E4883D-1A5A-46C8-9C3D-580DB2C86485Q39228039-D03CE54A-7794-4836-B2A9-4EBE7F053DF3Q39448303-D39FF5F5-C172-485E-AB05-361171A1A31CQ41493335-F5B3753B-2465-43DB-A866-EA09DA88074FQ41870476-48884C46-FEB3-4871-8C7E-ABB481D954B8Q42431588-7703D682-B5E2-477D-B36D-AB9656B6F0C2Q45933704-F66C683E-9D68-446C-81B0-4DCCEEA83B22Q46512368-B07A0493-55A9-4ECA-843F-2059E23128F2Q49592937-83179E0A-1095-4477-966E-83DD392E121CQ50423292-772FFA27-31B0-4C23-88F1-2FDBD0342E61Q55257766-AFCCB010-0E76-46D8-87E8-8F2FE08F3805Q57462243-F6345C5F-C4BE-4095-967F-1FDF7E1CEBDB
P2860
Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent manners
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Poly-ICLC promotes the infiltr ...... nd IFN-gamma dependent manners
@ast
Poly-ICLC promotes the infiltr ...... nd IFN-gamma dependent manners
@en
type
label
Poly-ICLC promotes the infiltr ...... nd IFN-gamma dependent manners
@ast
Poly-ICLC promotes the infiltr ...... nd IFN-gamma dependent manners
@en
prefLabel
Poly-ICLC promotes the infiltr ...... nd IFN-gamma dependent manners
@ast
Poly-ICLC promotes the infiltr ...... nd IFN-gamma dependent manners
@en
P2093
P2860
P1476
Poly-ICLC promotes the infiltr ...... nd IFN-gamma dependent manners
@en
P2093
Andres M Salazar
Beth A Fallert-Junecko
Edward R Kastenhuber
Heather A McDonald
Hideho Okada
Pawel Kalinski
Todd A Reinhart
Xinmei Zhu
P2860
P2888
P304
P356
10.1007/S00262-010-0876-3
P577
2010-06-12T00:00:00Z
P5875
P6179
1014058627